Clinical trial
Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell…
NCT00004100 · Istituto Nazionale per lo Studio e la Cura dei Tumori, Other · Unknown status
Key facts
| NCT number | NCT00004100 |
|---|---|
| Title | Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer |
| Official title | Gemcitabine and Vinorelbine vs Standard Chemotherapy Containing Cisplatin for Stage IIIB/IV Non-Small Cell Lung Cancer |
| Lead sponsor | Istituto Nazionale per lo Studio e la Cura dei Tumori, Other |
| Collaborators | NCIC Clinical Trials Group |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride, vinorelbine tartrate |
| Start date | Nov 1, 1998 |
| First posted | Apr 16, 2004 |
| Last update posted | Dec 18, 2013 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: